Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOSL1 | hg19_v2_chr11_-_65667884_65667895 | 0.86 | 1.2e-09 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_36019123 Show fit | 22.14 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
suprabasin |
|
chr1_+_150480551 Show fit | 18.24 |
ENST00000369049.4
ENST00000369047.4 |
extracellular matrix protein 1 |
|
chr1_+_150480576 Show fit | 18.04 |
ENST00000346569.6
|
extracellular matrix protein 1 |
|
chr18_+_21452964 Show fit | 16.70 |
ENST00000587184.1
|
laminin, alpha 3 |
|
chr18_+_21452804 Show fit | 14.36 |
ENST00000269217.6
|
laminin, alpha 3 |
|
chr1_-_153029980 Show fit | 13.95 |
ENST00000392653.2
|
small proline-rich protein 2A |
|
chr1_+_183155373 Show fit | 13.82 |
ENST00000493293.1
ENST00000264144.4 |
laminin, gamma 2 |
|
chr12_+_13349650 Show fit | 13.66 |
ENST00000256951.5
ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
epithelial membrane protein 1 |
|
chr6_+_47666275 Show fit | 13.62 |
ENST00000327753.3
ENST00000283303.2 |
G protein-coupled receptor 115 |
|
chr1_-_153013588 Show fit | 13.62 |
ENST00000360379.3
|
small proline-rich protein 2D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 54.6 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.9 | 54.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 36.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
8.4 | 25.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
4.8 | 19.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
3.1 | 18.4 | GO:0007296 | vitellogenesis(GO:0007296) |
1.9 | 15.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 14.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 14.4 | GO:0043486 | histone exchange(GO:0043486) |
0.8 | 14.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 96.0 | GO:0001533 | cornified envelope(GO:0001533) |
2.0 | 36.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
4.0 | 32.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 30.6 | GO:0005882 | intermediate filament(GO:0005882) |
6.5 | 19.5 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 16.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 14.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 14.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.7 | 14.4 | GO:0000812 | Swr1 complex(GO:0000812) |
2.2 | 13.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 71.0 | GO:0005198 | structural molecule activity(GO:0005198) |
4.3 | 34.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.4 | 26.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
1.7 | 24.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 23.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
3.8 | 19.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 17.6 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 15.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.5 | 14.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 14.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 57.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.6 | 39.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 36.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 25.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 17.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 17.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.4 | 12.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 12.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 11.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 10.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 50.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
1.1 | 19.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 14.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.5 | 13.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 12.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 11.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.6 | 10.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 10.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.3 | 9.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 9.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |